Thought Neil presented well. Said that they were at break even if you discounted R&D. All depends how quickly they can monetise the large number of opportunities they have.
16 more trading days left this year and we should/could have 2 juicy RNSs to come: - Green MSAR details - at least one Marine Trial LONO. Time to be positive? GLA Shipmates
From this mornings Avactar RNS they seem to be struggling to develop a saliva LFT test and are pushing ahead, for the time being, with swab tests. Does this mean that we are potentially "ahead of the game" Gerry??